Clinical Trials
28 trialsA Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma
National Cancer Institute (NCI)
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
National Cancer Institute (NCI)
INTerpath-007
Merck Sharp & Dohme LLC
Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma
Ohio State University Comprehensive Cancer Center
Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute
NeoDREAM
Philogen S.p.A.
SONIB
Melanoma Institute Australia
SENIOR-HN
University of Michigan Rogel Cancer Center
WoW
Vastra Gotaland Region
RTN2
Melanoma and Skin Cancer Trials Limited
Pivotal
Philogen S.p.A.
Rational-MCC
University of Birmingham
The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma
University of Aleppo
IMPACTE-01
Assistance Publique - Hôpitaux de Paris
OpACIN-neo
The Netherlands Cancer Institute
BCC Excision Revisited
Medical University of Vienna
ImiReduc
Nantes University Hospital
ISABELLA
MelanomaPRO, Russia
Serial Tumour Biopsies and Blood Biomarkers in Melanoma
The Christie NHS Foundation Trust
Reflectance Confocal Microscopy in Basal Cell Carcinoma
Radboud University Medical Center
Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer
National Cancer Institute (NCI)
Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study
H. Lee Moffitt Cancer Center and Research Institute
Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma
University of Utah
Biomarker Correlates of Hypoxia in Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute
B-OSS
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma
Barbara Ann Karmanos Cancer Institute
STG4SURG
Saint John's Cancer Institute
SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
SWOG Cancer Research Network